Scholarlink

Purpose <p>Fatigue is a common long-term complaint in childhood cancer patients and survivors. Treatment of pediatric bone sarcomas is intensive and can lead to physical, functional and psychosocial challenges; however, little is known about fatigue in this group. This study aimed to gain insight into fatigue and related demographic, medical, psychosocial, and lifestyle factors in pediatric bone sarcoma patients and survivors.</p> Methods <p>Patients treated for pediatric bone sarcoma, ≥ 2&#xa0;years post-diagnosis and after completion of treatment with no evidence of disease, completed PedsQL™ Multidimensional Fatigue Scale and PROMIS® fatigue measures. Prevalence and mean scores were compared with Dutch normative data using binomial tests, one-sample <i>t</i>-tests, and ANOVA. Linear regression analyses examined associations of fatigue with demographic and medical factors, psychological difficulties (measured with emotion thermometers), pain (measured with a numeric rating scale), and physical activity (using an accelerometer).</p> Results <p>In total, 139 patients participated. In children (<i>N</i> = 44), 51.6% (95% CI 34.0–69.2) reported moderate to severe fatigue, significantly higher than the weighted norm (29.8%), while adults (<i>N</i> = 95) (11.5%, 95% CI 4.4–18.6) did not differ from the weighted norm (12.1%). Children scored worse than the norm on all fatigue measures (Cohen’s <i>d</i> range = 0.58 to 1.10); adults did not significantly differ. Longer time since end of treatment was associated with less cognitive fatigue. More psychological difficulties and pain were associated with more fatigue, while higher levels of physical activity were associated with less fatigue.</p> Conclusion <p>Children after pediatric bone sarcoma experience more fatigue than the norm. More psychological difficulties, more pain, and less physical activity are associated with more fatigue. Medical factors are limited to time since end of treatment, where a longer time is associated with less cognitive fatigue.</p> Implications for Cancer Survivors <p>Screening for fatigue and associated factors during treatment and follow-up may help identify and support patients at risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fatigue after pediatric bone sarcoma: prevalence and associated factors in pediatric and adult patients and survivors after treatment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月1日

查看全文
  • Hinke van der Hoek,
  • Heleen Maurice-Stam,
  • Laura R. Beek,
  • Jennifer van Dijk,
  • Marjolein E. M. Langemeijer,
  • Relinde W. Slooff-Lentink,
  • Alied M. van der Aa- van Delden,
  • Hendrik W. B. Schreuder,
  • Lianne M. Haveman,
  • Willem P. Bekkering,
  • Leonie G. Tigelaar,
  • Johannes H. M. Merks,
  • Martha A. Grootenhuis,
  • Raphaële R. L. van Litsenburg

摘要

Purpose

Fatigue is a common long-term complaint in childhood cancer patients and survivors. Treatment of pediatric bone sarcomas is intensive and can lead to physical, functional and psychosocial challenges; however, little is known about fatigue in this group. This study aimed to gain insight into fatigue and related demographic, medical, psychosocial, and lifestyle factors in pediatric bone sarcoma patients and survivors.

Methods

Patients treated for pediatric bone sarcoma, ≥ 2 years post-diagnosis and after completion of treatment with no evidence of disease, completed PedsQL™ Multidimensional Fatigue Scale and PROMIS® fatigue measures. Prevalence and mean scores were compared with Dutch normative data using binomial tests, one-sample t-tests, and ANOVA. Linear regression analyses examined associations of fatigue with demographic and medical factors, psychological difficulties (measured with emotion thermometers), pain (measured with a numeric rating scale), and physical activity (using an accelerometer).

Results

In total, 139 patients participated. In children (N = 44), 51.6% (95% CI 34.0–69.2) reported moderate to severe fatigue, significantly higher than the weighted norm (29.8%), while adults (N = 95) (11.5%, 95% CI 4.4–18.6) did not differ from the weighted norm (12.1%). Children scored worse than the norm on all fatigue measures (Cohen’s d range = 0.58 to 1.10); adults did not significantly differ. Longer time since end of treatment was associated with less cognitive fatigue. More psychological difficulties and pain were associated with more fatigue, while higher levels of physical activity were associated with less fatigue.

Conclusion

Children after pediatric bone sarcoma experience more fatigue than the norm. More psychological difficulties, more pain, and less physical activity are associated with more fatigue. Medical factors are limited to time since end of treatment, where a longer time is associated with less cognitive fatigue.

Implications for Cancer Survivors

Screening for fatigue and associated factors during treatment and follow-up may help identify and support patients at risk.